Has Benzy Padanilam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,762 in general payments to Benzy Padanilam, MD across 197 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benzy Padanilam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benzy Padanilam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benzy Padanilam, MD

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1750350419

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.5%), other and ownership interests — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Topera, Inc. at 39.3% of the total. Reporting peaked in 2021 at $8,498 and has fallen 57.3% since, to $3,632 in 2025.

$28,762in general payments, 2019–2025

Across 197 payments — averaging $146.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Topera, Inc.$11K
Abbott$10K
Medtronic$4K
Boston Scientific$2K
Atricure, Inc.$316
Biosense Webster, Inc.$210
plus $810 from 8 others

$105,925in research payments, 2019–2025

Across 38 payments — averaging $2787.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$55K
Boston Scientific$50K
Boehringer Ingelheim$490

What the payments were for

Consulting fees$3,08811%
Travel & lodging$9893%
Food & beverage$13,37847%
Ownership interest$5,03718%
Other$6,27122%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Topera, Inc.	3	$11,307
Abbott	109	$10,078
Medtronic(2 entities)	40	$3,668
Boston Scientific	30	$2,371
Atricure, Inc.	3	$316
Biosense Webster, Inc.	2	$210
Impulse Dynamics (USA) Inc.	1	$183
Volta Medical Inc	1	$170
Cardiva Medical, Inc.	2	$161
Sanofi-aventis U.S. LLC	1	$125
Philips North America LLC	1	$123
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$17
Cvrx, Inc.	1	$16
Kiniksa Pharmaceuticals International, PLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ADVISOR$1,900
ENSITE$1,629
ENSITE PRECISION$1,274
EnSite Precision Cardiac Mapping System$1,067
Micra$605
Ensite Cardiac Mapping System$567
AFFERA MAPPING SYSTEM$529
OPTIMIZER$367
EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$233
RHYTHMIA$232
GENERAL - THERAPIES$190
VX1$170
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$162
WATCHMAN FLX$142
EMBLEM MRI S-ICD$141
Cobalt$140
VIGILANT X4 CRT-D$136
TACTICATH$135
AURORA EV-ICD MRI SURESCAN$133
AZURE XT DR MRI SURESCAN$129

How this compares

$28,762 in reported general payments places this provider in the 65th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana →

Medicare billing

Part B allowed, 2024

$193,434

Medicare patients

556

Services billed

2,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	354	$470,209
XareltoRivaroxaban	75	$89,998
EntrestoSacubitril/Valsartan	17	$17,645
Dofetilide	46	$8,626
Metoprolol Succinate	263	$3,526
Mexiletine Hcl	16	$2,748
Flecainide Acetate	80	$2,431
Diltiazem 24hr Er (Cd)Diltiazem Hcl	70	$1,837
Amiodarone Hcl	96	$1,465
SotalolSotalol Hcl	40	$872
Carvedilol	73	$556
Digoxin	19	$430
Warfarin Sodium	56	$418
Tiadylt ErDiltiazem Hcl	11	$367
ClopidogrelClopidogrel Bisulfate	17	$340

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Indianapolis

Eric PrystowskyIndianapolis$1.1M
Kevin TrulockIndianapolis$402K
Sharath VipparthyIndianapolis$114K
Jasen GilgeIndianapolis$93K
Vincent KeatingIndianapolis$80K
Christopher ReedIndianapolis$80K
Marcelle StuckyIndianapolis$76K
Joseph SzwedIndianapolis$67K
Krishna MalineniIndianapolis$65K
Anil PurohitIndianapolis$45K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →